CNBC.com's News Now

Wednesday, Mar. 12, 2008

1. NY Governor Eliot Spitzer Resigns: Eliot Spitzer announces his resignation as NY Governor. 2. Abolish the Fed: If Jim Rogers, CEO of Rogers Holdings, woke up as Ben Bernanke, he'd quit and close up the Federal Reserve for providing "socialism for the rich." 3. Bear Stearns CEO: Discussing the incessant rumors of liquidity problems, with Alan Schwartz, Bear Stearns CEO, and CNBC's David Faber. 4. Stop Trading, Listen to Cramer! Mad Money host Jim Cramer shares his stock picks with CNBC's Erin Burnett. 5. GE Report: Thoughts on the annual report from the Dow component (and CNBC parent), with Mike Holland, Holland & Company chairman, and CNBC's Melissa Lee. Where Is The Economy's Breaking Point? When oil was climbing past $50, $60, $70 and even $80 a barrel, the big question was: Where is the breaking point for the economy? Now with the economy staring down a recession (or in a recession, depending on your view), oil is at $110 per barrel. And some economists are saying the price is now beyond that breaking point . Click here to view posting.

ECO:NOMICS The Wall Street Journal hosts the ECO:nomics Conference in Santa Barbara, CA where CEOs gather to discuss the developing relationships between the environment and the bottom line. With new opportunities and innovative technology emerging, the possibilities are vast, but the risks can be high as well. Who will end up leading the way in eco-friendly business with a subsequent increase in profit? Melissa Francis sits down with the brightest in the boardroom from GE's Jeff Immelt to Wal-Mart's Lee Scott. ECON DATA/RETAIL SALES: Steve Liesman parses the retail sales numbers to headline the underlying consumer story. Are consumers sloughing off slowdown fears and continuing to buy, buy, buy? ANEMIA DRUGS IN THE CROSSHAIRS: While many are pushing for the double-use of some anemia drugs for cancer patients, an FDA advisory committee is meeting to discuss restricting use, as over-use of the drug can be harmful, making cancer worse and increasing death rates in patients. Anemia drugs are a multi-billion dollar pharma sector, and Amgen and Johnson & Johnson stock have major downside risk if the committee advises against their drugs. Mike Huckman looks at what's at stake. FEBRUARY FORECLOSURES: RealtyTrac releases February foreclosure numbers early Thursday morning. The economy waits for hopeful news to lift the ailing real estate market. Diana Olick reports the latest to paint the picture of the nation's foreclosures. Will the data disappoint? Portfolio Watchlist Insider Trends Financial Glossary Stock Screeners Fund Screeners Earnings Screeners

To unsubscribe to this email click here If this e-mail was forwarded to you and you would like to subscribe to CNBC.com's News Now mailing, please click here